Elevance Health (ELV) Net Margin (2009 - 2026)

Elevance Health (ELV) has 17 years of Net Margin data on file, last reported at 3.56% in Q1 2026.

• Net Margin for Q1 2026 came in at 3.56%, down 91.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 2.44% (down 80.0% YoY), and the FY2025 annual result was 2.87%, down 51.0% from the prior year.
• Net Margin rose to 3.56% in Q1 2026 per ELV's latest filing, from 0.74% in the prior quarter.
• Over five years, Net Margin peaked at 5.43% in Q1 2022 and troughed at 0.74% in Q4 2025.
• A 5-year average of 3.51% and a median of 3.69% in 2023 frame the typical range for Net Margin.
• The sharpest annual moves came in 2022 and 2023: Net Margin plunged 208 bps in 2022, then surged 84 bps in 2023.
• A 5-year view of Net Margin shows it stood at 1.54% in 2022, then surged by 30 bps to 2.0% in 2023, then plunged by 55 bps to 0.91% in 2024, then fell by 18 bps to 0.74% in 2025, then jumped by 380 bps to 3.56% in 2026.
• Business Quant data shows ELV's Net Margin at 3.56% in Q1 2026, 0.74% in Q4 2025, and 2.84% in Q3 2025.